Immunovant (IMVT)
(Delayed Data from NSDQ)
$28.31 USD
-0.11 (-0.39%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $28.32 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.62 |
EPS Last Quarter | -0.60 |
Last EPS Surprise | -15.38% |
ABR | 1.00 |
Earnings ESP
|
-0.54% |
---|---|
Current Year | -2.43 |
Next Year | -2.69 |
EPS (TTM) | -1.93 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 68.42M |
# of Estimates | NA | NA | NA | 3 |
High Estimate | NA | NA | NA | 148.50M |
Low Estimate | NA | NA | NA | 6.77M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.62 | -0.61 | -2.43 | -2.69 |
# of Estimates | 9 | 8 | 10 | 6 |
Most Recent Consensus | -0.62 | -0.61 | -2.45 | -2.82 |
High Estimate | -0.55 | -0.55 | -1.88 | -2.19 |
Low Estimate | -0.69 | -0.65 | -2.86 | -3.05 |
Year ago EPS | -0.45 | -0.36 | -1.78 | -2.43 |
Year over Year Growth Est. | -37.78% | -69.44% | -36.52% | -10.60% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 2 |
Down Last 60 Days | 7 | 7 | 9 | 5 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Current | -0.62 | -0.61 | -2.43 | -2.69 |
7 Days Ago | -0.62 | -0.61 | -2.43 | -2.69 |
30 Days Ago | -0.61 | -0.60 | -2.41 | -2.61 |
60 Days Ago | -0.54 | -0.54 | -2.11 | -2.31 |
90 Days Ago | -0.54 | -0.54 | -2.11 | -2.31 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.62 | -0.61 | -2.45 | -2.75 |
Zacks Consensus Estimate | -0.62 | -0.61 | -2.43 | -2.69 |
Earnings ESP | -0.54% | -0.62% | -0.66% | -1.98% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.60 | -0.52 | -0.36 | -0.45 | NA |
Estimate | -0.52 | -0.43 | -0.44 | -0.46 | NA |
Difference | -0.08 | -0.09 | 0.08 | 0.01 | -0.02 |
Surprise | -15.38% | -20.93% | 18.18% | 2.17% | -3.99% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more